Yarur, Andres http://orcid.org/0000-0003-2293-5555
Mantzaris, Gerassimos J.
Wang, Song
Adsul, Shashi
Kamble, Pravin
Cook, Erin
Sajeev, Gautam
Guerin, Annie
Bressler, Brian
Funding for this research was provided by:
Takeda Pharmaceuticals International
Cedars-Sinai Medical Center
Article History
Received: 5 December 2023
Accepted: 19 February 2024
First Online: 24 April 2024
Declarations
:
: Andres Yarur reports serving on advisory boards for Arena, Bristol Myers Squibb, Prometheus Laboratories, and Takeda. Gerassimos J. Mantzaris reports research grants from AbbVie, Genesis, MSD, and Takeda, and being an adviser/speaker for AbbVie, Aenorasis, Dr Falk Pharma, Ferring, Hospira, Janssen, MSD, MYLAN, Pfizer, Takeda, and Vianex. Song Wang, Shashi Adsul, and Pravin Kamble are employees of the study sponsor, Takeda, and hold stock or stock options in Takeda. Erin Cook, Gautam Sajeev, and Annie Guerin are employees of Analysis Group, who were contracted by Takeda to perform this analysis. Brian Bressler reports being an adviser/speaker for AbbVie, Bristol Myers Squibb, Ferring, Janssen, Merck, Novartis, Pfizer, and Takeda; adviser for Alimentiv, Allergan, Amgen, AMT, Bristol Myers Squibb, Celgene, Fresenius Kabi, Genentech, Gilead, Iterative Scopes, Merck, Microbiome Insights, Mylan, Pendopharm, and Protagonist; research support from AbbVie, Alvine, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Genentech, GlaxoSmithKline, Janssen, Merck, and Qu Biologic; and stock options in Qu Biologic.
: The study was approved by the local ethics committee at each participating site. Patients alive at the time of chart abstraction (99% of patients) signed an informed consent form prior to participation in the study if there was no waiver of informed consent.